FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198530821> ?p ?o ?g. }

• W3198530821 endingPage "1937" @default.
• W3198530821 startingPage "1929" @default.
• W3198530821 abstract "INTRODUCTION: Linaclotide improves abdominal pain and constipation in patients with constipation-predominant irritable bowel syndrome (IBS-C). Patients report additional bothersome abdominal symptoms of bloating and discomfort. The intention of this study was to evaluate linaclotide's efficacy in relieving IBS-C-related abdominal symptoms (bloating, discomfort, and pain) using a novel multi-item Abdominal Score (AS). METHODS: Patients with IBS-C with abdominal pain ≥3 (0–10 scale) were randomized to linaclotide 290 μg or placebo daily for 12 weeks. The AS, derived from the Diary for IBS Symptoms-Constipation, is the average of abdominal bloating, discomfort, and pain at their worst (0 = none, 10 = worst possible). The primary end point was overall change from baseline (CFB) in AS. Secondary end points included CFB in 12-week AS evaluated using cumulative distribution function and 6-week/12-week AS responder (AS improvement ≥2 points for ≥6-week/12-week). RESULTS: Overall, 614 patients (mean age 46.7 years; 81% female) were randomized. All prespecified end points showed significant benefit of linaclotide vs placebo. The mean overall CFB AS reduction for linaclotide was −1.9 vs −1.2 for placebo ( P < 0.0001); the 6-week/12-week AS responder rate was 40.5% for linaclotide vs 23.4% for placebo (odds ratio = 2.2 [95% confidence interval, 1.55–3.12; P < 0.0001]). Diarrhea was the most common treatment-emergent adverse event (linaclotide = 4.6%, placebo = 1.6%). DISCUSSION: Linaclotide significantly reduced multiple abdominal symptoms important to patients with IBS-C (bloating, discomfort, and pain) compared with placebo, as measured by a novel multi-item AS. The AS, derived from the Diary for IBS Symptoms-Constipation, should be considered for use in future IBS-C clinical studies to measure clinically meaningful improvements beyond traditional end points." @default.
• W3198530821 created "2021-09-13" @default.
• W3198530821 creator A5027479348 @default.
• W3198530821 creator A5033097087 @default.
• W3198530821 creator A5034189419 @default.
• W3198530821 creator A5036398609 @default.
• W3198530821 creator A5037965097 @default.
• W3198530821 creator A5038294897 @default.
• W3198530821 creator A5040662240 @default.
• W3198530821 creator A5048152931 @default.
• W3198530821 creator A5048674574 @default.
• W3198530821 creator A5057711127 @default.
• W3198530821 creator A5061045517 @default.
• W3198530821 creator A5068697150 @default.
• W3198530821 creator A5078318374 @default.
• W3198530821 creator A5081003981 @default.
• W3198530821 creator A5086017036 @default.
• W3198530821 date "2021-06-11" @default.
• W3198530821 modified "2023-10-14" @default.
• W3198530821 title "Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System" @default.
• W3198530821 cites W1648481394 @default.
• W3198530821 cites W1951179596 @default.
• W3198530821 cites W1956460762 @default.
• W3198530821 cites W1987172422 @default.
• W3198530821 cites W1988687339 @default.
• W3198530821 cites W1997800332 @default.
• W3198530821 cites W2005264371 @default.
• W3198530821 cites W2009552042 @default.
• W3198530821 cites W2012787213 @default.
• W3198530821 cites W2022599897 @default.
• W3198530821 cites W2025845157 @default.
• W3198530821 cites W2032964333 @default.
• W3198530821 cites W2037284544 @default.
• W3198530821 cites W2044044822 @default.
• W3198530821 cites W2064017014 @default.
• W3198530821 cites W2064201279 @default.
• W3198530821 cites W2064372452 @default.
• W3198530821 cites W2079448135 @default.
• W3198530821 cites W2116511946 @default.
• W3198530821 cites W2120648209 @default.
• W3198530821 cites W2126354955 @default.
• W3198530821 cites W2263011621 @default.
• W3198530821 cites W2568071031 @default.
• W3198530821 cites W2894650121 @default.
• W3198530821 cites W2963832375 @default.
• W3198530821 cites W2999331904 @default.
• W3198530821 cites W3007912193 @default.
• W3198530821 cites W3014186221 @default.
• W3198530821 cites W3016212206 @default.
• W3198530821 cites W3092931770 @default.
• W3198530821 cites W4211073917 @default.
• W3198530821 cites W4249317513 @default.
• W3198530821 doi "https://doi.org/10.14309/ajg.0000000000001334" @default.
• W3198530821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34465695" @default.
• W3198530821 hasPublicationYear "2021" @default.
• W3198530821 type Work @default.
• W3198530821 sameAs 3198530821 @default.
• W3198530821 citedByCount "10" @default.
• W3198530821 countsByYear W31985308212021 @default.
• W3198530821 countsByYear W31985308212022 @default.
• W3198530821 countsByYear W31985308212023 @default.
• W3198530821 crossrefType "journal-article" @default.
• W3198530821 hasAuthorship W3198530821A5027479348 @default.
• W3198530821 hasAuthorship W3198530821A5033097087 @default.
• W3198530821 hasAuthorship W3198530821A5034189419 @default.
• W3198530821 hasAuthorship W3198530821A5036398609 @default.
• W3198530821 hasAuthorship W3198530821A5037965097 @default.
• W3198530821 hasAuthorship W3198530821A5038294897 @default.
• W3198530821 hasAuthorship W3198530821A5040662240 @default.
• W3198530821 hasAuthorship W3198530821A5048152931 @default.
• W3198530821 hasAuthorship W3198530821A5048674574 @default.
• W3198530821 hasAuthorship W3198530821A5057711127 @default.
• W3198530821 hasAuthorship W3198530821A5061045517 @default.
• W3198530821 hasAuthorship W3198530821A5068697150 @default.
• W3198530821 hasAuthorship W3198530821A5078318374 @default.
• W3198530821 hasAuthorship W3198530821A5081003981 @default.
• W3198530821 hasAuthorship W3198530821A5086017036 @default.
• W3198530821 hasBestOaLocation W31985308211 @default.
• W3198530821 hasConcept C126322002 @default.
• W3198530821 hasConcept C142724271 @default.
• W3198530821 hasConcept C168563851 @default.
• W3198530821 hasConcept C203092338 @default.
• W3198530821 hasConcept C204787440 @default.
• W3198530821 hasConcept C27081682 @default.
• W3198530821 hasConcept C2776956441 @default.
• W3198530821 hasConcept C2778271842 @default.
• W3198530821 hasConcept C2780955771 @default.
• W3198530821 hasConcept C2781112942 @default.
• W3198530821 hasConcept C71924100 @default.
• W3198530821 hasConcept C90924648 @default.
• W3198530821 hasConceptScore W3198530821C126322002 @default.
• W3198530821 hasConceptScore W3198530821C142724271 @default.
• W3198530821 hasConceptScore W3198530821C168563851 @default.
• W3198530821 hasConceptScore W3198530821C203092338 @default.
• W3198530821 hasConceptScore W3198530821C204787440 @default.
• W3198530821 hasConceptScore W3198530821C27081682 @default.
• W3198530821 hasConceptScore W3198530821C2776956441 @default.
• W3198530821 hasConceptScore W3198530821C2778271842 @default.

• next